Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The overarching goal of this study is to characterize the acute cognitive and
psychophysiological effects of the main psychoactive constituent of cannabis,
9-delta-tetrahydrocannabinol (THC) in individuals with euthymic bipolar disorder (BD), and to
begin probing the mechanisms that may underlie its effects in this illness.
This study is expected to contribute to a better characterization of specific effects of THC
in individuals with BD compared to healthy controls (HC).